NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY

.

Bibliographic Details
Main Author:	article editorial
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2017-01-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Online Access:	https://www.rpcardio.com/jour/article/view/1386

Similar Items

New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer)
by: Article Editorial
Published: (2016-09-01)

The Results of Rivaroxaban Studies COMMANDER HF and MARINER Were Published. Bayer Company Press Release .
by: artilce Editorial
Published: (2019-01-01)

The relevance of interdependence between headquarter and subsidiary organisations for product launch outcomes. An in-depth analysis of the launch of Xarelto® in the Bayer Healthcare organisation.
by: Van Unen, Marc
Published: (2012)

BAYER HEALTHCARE
Published: (2015-04-01)

Actitud Bayer
by: Diana Lenton
Published: (2019-12-01)

Raymond Bayer
Published: (2010-05-01)

Negotiation between Transnational Companies and Host Country; The case of Bayer Investment in Taichung Harbor Area
by: Pi-Jen Tung, et al.
Published: (1999)

RIVAROXABAN OF THE BAYER COMPANY SIGNIFICANTLY (BY 24%) REDUCES THE RISK OF STROKE, CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE OR PERIPHERAL ARTERIAL DISEASE
by: статья Редакционная
Published: (2017-11-01)

Antisolvent gibbsite crystallisation from synthetic Bayer liquor
by: Chiang, Yu-Lun
Published: (2014)

Incident Cause Pattern Analysis at Bayer
by: Jan Weppelmann
Published: (2016-04-01)

A soft sensor for the Bayer process
by: Vincent Cregan, et al.
Published: (2017-05-01)

The investigation of scale formation in the Bayer process
by: Armstrong, Jennifer Ann
Published: (1999)

Investigation of scale formation in the Bayer process
by: Kenyon, Nicola Jane
Published: (2003)

Reversible Data Hiding for Bayer Pattern
by: Jia-wei Fang, et al.
Published: (2012)

Global Competence Management for Process & Plant Safety at Bayer
by: Hans-Erich Gasche, et al.
Published: (2016-04-01)

Green Channel Guiding Denoising on Bayer Image
by: Xin Tan, et al.
Published: (2014-01-01)

Distribution of Selected Trace Elements in the Bayer Process
by: Johannes Vind, et al.
Published: (2018-05-01)

The effects of an organic phosphate compound (Bayer 21
by: Milleret, Roy Joseph.
Published: (2015)

Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA
by: Bayer Company Press Release
Published: (2018-11-01)

The effect of calcium-containing reagents on Bayer leaching of bauxites
by: S.А. Bibanaeva, et al.
Published: (2017-12-01)

Noticias clinicas: El Solusalvarsan (Bayer) en Sifiliterapia
by: Angel María Romero G.
Published: (1933-07-01)

'n Strategiese veiligheidsbestuursmodel vir Bayer se oesbeskermingsdivisie
by: Van der Walt, C. J.
Published: (2015)

Findings Released from NAXOS Analysis. Pfizer Company Press Release
by: article Editorial
Published: (2019-11-01)

Microbiological Leaching of Al from the Waste of Bayer Process by Some Selective Fungi
by: Yousef Ghorbani, et al.
Published: (2009-03-01)

Flower-like boehmite nanopowders obtained at low temperature from Bayer liquor
by: Marija Milanović, et al.
Published: (2020-05-01)

Artificial neural network prediction of the aluminum extraction from bauxite in the Bayer process
by: Đurić Isidora, et al.
Published: (2012-01-01)

Obtaining of transition phases of alumina starting from sodium aluminate in Bayer process
by: Obrenović Zoran, et al.
Published: (2011-01-01)

Preparation of mullite ceramics from bayer electrofilter fines and low kaolinite clay
by: Tutić Erna, et al.
Published: (2016-01-01)

A Study on Strategy of Sustainable Development - A Case on Bayer
by: Yeh, Ya Ting, et al.

Blind Correction of Lateral Chromatic Aberration in Raw Bayer Data
by: Stefan Petersson, et al.
Published: (2021-01-01)

Almacenes Bayer, Alemania, y Banco Alemán de Leverkusen
by: P. Schaeffer Heyrothsberge
Published: (1960-10-01)

Properties Analysis of Asphalt Binders Containing Bayer Red Mud
by: Liyang Yao, et al.
Published: (2020-03-01)

Experimental and Theoretical Studies on the Creep Behavior of Bayer Red Mud
by: Baoyun Zhao, et al.
Published: (2018-01-01)

Processing of low-quality bauxite feedstock by thermochemistry-Bayer method
by: О. А. Дубовиков, et al.
Published: (2016-11-01)

Optimising Ambient Setting Bayer Derived Fly Ash Geopolymers
by: Evan Jamieson, et al.
Published: (2016-05-01)

FOVEON VS BAYER: COMPARISON OF 3D RECONSTRUCTION PERFORMANCES
by: M. Vlachos, et al.
Published: (2019-01-01)

An Efficient Barrel Distortion Correction Processor for Bayer Pattern Images
by: Tae-Hwan Kim
Published: (2018-01-01)

Lossless Compression in Bayer Color Filter Array for Capsule Endoscopy
by: Shahed K. Mohammed, et al.
Published: (2017-01-01)

K. Lundbaeck. T. S. Bayer (1964-1738) : pioneer sinologist. Curzon Press, 1986. xiv, 241 p.
by: Russell Maeth Ch.
Published: (1989-05-01)

A Medwatch review of reported events in patients who discontinued rivaroxaban (XARELTO) therapy in response to legal advertising
by: Paul Burton, MD, PhD, FACC, et al.
Published: (2016-05-01)